Journal article

Stat3: Linking inflammation to (gastrointestinal) tumourigenesis

M Ernst, TL Putoczki

Clinical and Experimental Pharmacology and Physiology | WILEY | Published : 2012

Abstract

Tumourigenesis is a multistage process comprising initiation, promotion and progression that is governed by cumulative (epi-)genetic changes. However, tumour initiation, triggered by mutations in proto-oncogenes and/or tumour suppressor genes, is insufficient for the development of cancers. Tumour promotion often depends on the interaction between initiated cells and the microenvironment where an excessive abundance of inflammatory mediators, including those of the interleukin (IL-)6/glycoprotein 130 (gp130) family, promote their expansion. The activity of most soluble mediators ultimately converges on tumour cells through activation of the latent transcription factors nuclear factor (NF)-κB..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Health and Medical Research Council of Australia (NHMRC)


Funding Acknowledgements

The authors thank all members of the Colon Biology Laboratory for their valuable contributions. The authors' work reported herein was supported by funds from the Operational Infrastructure Support Program provided by the Victorian Government and grants from the Contributing to Australian Scholarship and Science (CASS) foundation, Cure Cancer Australia and the National Health and Medical Research Council of Australia (NHMRC; grants 433617, 487922, 603121 and 603122). ME is an NHMRC Senior Research Fellow.